Autophagy and oxidative stress in gliomas with IDH1 mutations
about
Targeting autophagy to sensitive glioma to temozolomide treatmentMitochondrial control by DRP1 in brain tumor initiating cells.Long noncoding RNAs and novel inflammatory genes determined by RNA sequencing in human lymphocytes are up-regulated in permanent atrial fibrillation.Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy.Preferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsPLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas.Isocitrate dehydrogenase 1 and 2 mutations in gliomas.Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumoursMutant IDH1 and thrombosis in gliomas.Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells.Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL.Wild-type and mutated IDH1/2 enzymes and therapy responses.Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity.Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system.H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling
P2860
Q28066270-C6E394A1-E625-4F92-B1A5-0D155DD7E2EEQ30300490-E3811C38-A767-4BBF-A6F1-459D20428803Q33733194-C61A5693-92C5-4D63-A36F-A50251468CB6Q34135404-04F77816-8178-453F-8D62-ABDAF5FA9E93Q34364774-FFDA6096-10D8-42D0-92E3-306D9B6F989AQ34539504-35211443-F1FD-4E89-A812-1C3BAE52B455Q36282985-45E4ACBF-2A06-4D3B-8E9D-69D598C0E4DBQ37716625-109FA8B6-B21C-4D9D-A9A5-5715D7FD981BQ38235572-61973137-C9E9-4C2F-93BC-D36FE979A8E3Q38375735-DD978DA8-AE9B-41A2-9C92-1B726CCD969CQ39355644-F94A2032-5B8A-4B2A-8F53-B4AD33D5B59AQ41919095-1BB57119-1DC1-4138-A8BA-44A3A0FBAA68Q42652909-BE1E3437-3E96-48B1-A1EC-489717D04874Q47713415-3E6287A6-895D-4F46-9894-F16F82C99E60Q48731754-51DB0EF6-4630-42A7-9B34-11660BCB3700Q55456883-761B71D2-6A59-46D5-9FDF-FBD344E7A176Q55457298-6CCADD82-1E90-4A3C-BBC6-BAB255D9817BQ57485200-FF492291-D7C8-407C-B931-0AA9840E1641
P2860
Autophagy and oxidative stress in gliomas with IDH1 mutations
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autophagy and oxidative stress in gliomas with IDH1 mutations
@en
Autophagy and oxidative stress in gliomas with IDH1 mutations.
@nl
type
label
Autophagy and oxidative stress in gliomas with IDH1 mutations
@en
Autophagy and oxidative stress in gliomas with IDH1 mutations.
@nl
prefLabel
Autophagy and oxidative stress in gliomas with IDH1 mutations
@en
Autophagy and oxidative stress in gliomas with IDH1 mutations.
@nl
P2093
P2860
P1476
Autophagy and oxidative stress in gliomas with IDH1 mutations
@en
P2093
Andrew Morris
Craig Horbinski
Janna Neltner
Manjula Sunkara
Misty R Gilbert
Natasha Kyprianou
Thomas Pittman
Yinxing Liu
P2860
P2888
P304
P356
10.1007/S00401-013-1194-6
P577
2013-10-23T00:00:00Z